Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AstraZeneca B7-H4-expressing advanced solid tumor study
NL-OMON53228Recruiting
- Sponsor
- AstraZeneca
- Start
- Mar 2024
- Countries
- 1
01
Overview
Trial in ovarian cancer, endometrial cancer (EC), biliary cancer and 2 more, sponsored by AstraZeneca. Started Mar 2024; status: recruiting.
02
Conditions
ovarian cancerendometrial cancer (EC)biliary cancerbreast cancerPulmonary squamous cell carcinoma
Beyond the preview
Go deeper on NL-OMON53228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53228.